# DESCRIPTION

## BACKGROUND

- introduce heart transplantation
- motivate need for predicting PGD

## SUMMARY

- introduce method for identifying PGD risk
- describe measuring PGD marker level
- quantify PGD risk value using MCCV model
- identify PGD risk based on PGD risk value
- introduce method for predicting post-transplant survival
- describe systems for identifying PGD risk and predicting post-transplant survival

## DETAILED DESCRIPTION

- define terms used in the patent
- provide open-ended transitional phrases
- define "about" or "approximately"
- define "coupled"
- define "subject"
- introduce method for identifying PGD risk
- collect sample from subject
- measure PGD marker level from sample
- provide PGD risk value
- identify PGD risk based on PGD risk value
- measure additional marker level from sample
- describe mass spectrometry analysis
- describe ELISA assay
- perform protein expression analysis
- conduct pathway analysis using GSEA
- assess protein prediction contribution
- provide PGD risk value using adaptive MCCV model
- generate putative PGD classifiers
- identify PGD risk based on PGD risk value
- evaluate disclosed information for increasing classification power
- assess effect of therapy on heart transplant
- provide system for predicting PGD and/or treating/preventing PGD
- provide methods for predicting post-transplant survival
- introduce method for predicting post-transplant survival
- obtain characteristics of subject
- measure post-transplant survival marker levels
- describe mass spectrometry analysis
- perform protein expression analysis
- calculate differential protein expression signature
- conduct pathway analysis using GSEA
- assess protein prediction contribution
- provide transplant risk value using adaptive MCCV model
- describe MCCV technique
- generate putative transplant risk classifiers
- identify likelihood of post-transplant survival
- evaluate characteristic of subject for transplant risk
- combine proteomics and clinical variables for classification
- assess effect of therapy on heart transplant
- provide system for predicting post-transplant survival
- describe processor configuration for collecting sample
- receive information related to subject characteristics
- measure post-transplant survival marker levels
- provide transplant risk value using adaptive MCCV model
- identify risk to post-transplant survival

### EXAMPLES

- introduce primary graft dysfunction (PGD) after heart transplant
- define PGD and its grading
- motivate molecular biomarkers for PGD prediction
- describe patient cohorts and blood sample collection
- outline mass spectrometry analysis of patient samples
- perform protein expression analysis and pathway enrichment
- predict PGD using logistic regression model
- describe Monte Carlo cross-validation strategy
- estimate prediction variance using bootstrapping
- compare PGD prediction probabilities to true PGD status
- perform permutation analysis to generate random prediction distribution
- analyze patient clinical characteristics
- identify significant clinical characteristics associated with PGD
- analyze protein expression in patient cohorts
- identify proteins present in every patient across all cohorts
- predict PGD using clinical and protein markers
- compare performance of clinical and protein markers
- investigate two-marker panel predictions
- analyze biological pathways enriched in PGD patients
- validate KLKB1 ELISA assay in PGD patients
- evaluate PGD classifier performance
- compare disclosed prediction panel to existing PGD predictors
- discuss implications of findings on PGD pathogenesis and clinical tests
- introduce examples
- integrate proteomic and clinical variables
- test microvesicular process
- normalize KLKB1 values
- discuss clinical utility
- introduce example 2
- describe patient cohorts
- outline study design
- detail mass spectrometry analysis
- perform protein expression analysis
- calculate differential protein expression signature
- estimate protein association with survival
- perform pathway analysis
- conduct survival prediction
- describe Monte Carlo Cross Validation
- report results
- describe patient clinical characteristics
- analyze microvesicle proteomics
- predict post-transplant survival
- discuss predictive profiles
- investigate biological pathways

